Evaluating cardiac risk: exposure response analysis in early clinical drug development

por Grenier, Julie, Paglialunga, Sabina, Morimoto, Bruce H, Lester, Robert M
Publicado 2018

Tracking the Sugar Rush: Incorporating Continuous Glucose Monitoring Into Multisite Early Clinical Research With Type 2 Diabetes Subjects

por Paglialunga, Sabina, Morimoto, Bruce H., de la Peña, Amparo, Fortier, Caroline
Publicado 2018

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

por Gold, Michael, Lorenzl, Stefan, Stewart, Alistair J, Morimoto, Bruce H, Williams, David R, Gozes, Illana
Publicado 2012

Pharmacokinetics in Rat of P8, a Peptide Drug Candidate for the Treatment of Alzheimer’s Disease: Stability and Delivery to the Brain(1)

por Dewji, Nazneen N., Azar, Marc R., Hanson, Leah R., Frey II, William H., Morimoto, Bruce H., Johnson, David
Publicado 2018

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein

por Magen, Iddo, Ostritsky, Regina, Richter, Franziska, Zhu, Chunni, Fleming, Sheila M, Lemesre, Vincent, Stewart, Alistair J, Morimoto, Bruce H, Gozes, Illana, Chesselet, Marie-Françoise
Publicado 2014